For instance, a study optimizing an MAGE-A1-specific TCR via somatic hypermutation demonstrated that T cells with enhanced avidity exhibited significantly higher IFN-γ production and cytotoxicity against melanoma cells, both in vitro and in mouse models [34]. This evidence concerns the gene MAGEA1 and melanoma.